218 related articles for article (PubMed ID: 11097148)
1. Selection criteria for breast conservation in breast cancer.
Sakorafas GH; Tsiotou AG
Eur J Surg; 2000 Nov; 166(11):835-46. PubMed ID: 11097148
[TBL] [Abstract][Full Text] [Related]
2. Management of ductal carcinoma in situ of the breast. Provincial Breast Cancer Disease Site Group.
Wright JR; Whelan TJ; McCready DR; O'Malley FP
Cancer Prev Control; 1998 Dec; 2(6):312-9. PubMed ID: 10470463
[No Abstract] [Full Text] [Related]
3. [Surgical treatment of carcinoma in situ of the breast].
Gangi S; Costanzo MP; Furci M; Khansa K; Basile F
Ann Ital Chir; 1995; 66(1):47-50; discussion 50-1. PubMed ID: 7668482
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of local recurrence after breast-conserving therapy in young patients.
Baltoyiannis G; Roukos DH; Fatouros M
Radiother Oncol; 2008 Feb; 86(2):286-7; author reply 287-8. PubMed ID: 17963905
[No Abstract] [Full Text] [Related]
5. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
[TBL] [Abstract][Full Text] [Related]
6. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
7. Eleven-year follow-up results in the delay of breast irradiation after conservative breast surgery in node-negative breast cancer patients.
Vujovic O; Yu E; Cherian A; Dar AR; Stitt L; Perera F
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):760-4. PubMed ID: 16246494
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy.
Jiveliouk I; Corn B; Inbar M; Merimsky O
Oncology; 2009; 76(1):30-5. PubMed ID: 19033713
[TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ--the focus for prevention, screening, and breast conservation in breast cancer.
Page DL; Simpson JF
N Engl J Med; 1999 May; 340(19):1499-500. PubMed ID: 10320390
[No Abstract] [Full Text] [Related]
10. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
11. [Unresolved questions in the indications for the conservative treatment of invasive cancer of the breast].
Zinzindohoué C; Bobin JY
Bull Cancer; 1998 Sep; 85(9):763-72. PubMed ID: 9817060
[TBL] [Abstract][Full Text] [Related]
12. [Controversies in breast conservation treatment for breast cancer].
Motomura K; Egawa C; Komoike Y; Inaji H; Koyama H
Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746
[TBL] [Abstract][Full Text] [Related]
13. Breast conservation therapy in the management of invasive and in situ carcinoma.
Masko GB; Triedman SA; Brotman RL; Webber BM; Yu A
R I Med; 1995 Sep; 78(9):246-9. PubMed ID: 7579719
[No Abstract] [Full Text] [Related]
14. Breast conservation in patients with multiple ipsilateral synchronous cancers.
Kaplan J; Giron G; Tartter PI; Bleiweiss IJ; Estabrook A; Smith SR
J Am Coll Surg; 2003 Nov; 197(5):726-9. PubMed ID: 14585405
[TBL] [Abstract][Full Text] [Related]
15. Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first.
Bollet MA; Sigal-Zafrani B; Mazeau V; Savignoni A; de la Rochefordière A; Vincent-Salomon A; Salmon R; Campana F; Kirova YM; Dendale R; Fourquet A
Radiother Oncol; 2007 Mar; 82(3):272-80. PubMed ID: 17287037
[TBL] [Abstract][Full Text] [Related]
16. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.
Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E
Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877
[TBL] [Abstract][Full Text] [Related]
17. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis.
Ben-David MA; Kleer CG; Paramagul C; Griffith KA; Pierce LJ
Cancer; 2006 Jan; 106(1):28-34. PubMed ID: 16329136
[TBL] [Abstract][Full Text] [Related]
18. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
19. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
20. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
